EUVIMEDEUVIMED entdecken
Validierungsstudie

ICH Q14‐inspired novel approach to establish an SFC‐based purity method for carbamazepine

Alexander H Schmidt iD, Mijo Stanic, Maria Kristina Parr iD

Drug Testing and Analysis · 2024

DOI: 10.1002/dta.3635 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Alexander H Schmidt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chromicent GmbH, Berlin Adlershof, Germany. Hauptthemen laut MEDLINE: Carbamazepine, Chromatography, Supercritical Fluid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The proposed ICH Q14 guideline “Analytical procedure development” describes science and risk‐based approaches for development and maintenance of analytical procedures suitable for the assessment of the quality of drug substances and drug products. As a case study, the systematic development and validation of a supercritical fluid chromatography (SFC)‐based purity method for carbamazepine is presented. Systematic analytical quality by design (AQbD) principles were applied using the software package Fusion QbD to the method development approach. The relationship between chromatographic parameters and the responses of interest were examined to improve the reliability of the method by understanding, reducing, and controlling sources of variability. Method performance qualification in terms of method robustness was finally carried out with the parameters that were classified as critical after method development and a validation study met previously set acceptance criteria. The developed SFC purity method for carbamazepine demonstrated readiness as a viable alternative to the official HPLC method published in the Ph.Eur. with improved peak resolution, improved peak symmetry, and faster analysis times (3 min vs. 80 min for the official method). Its inherent reliability illustrates the superiority of AQbD in method development and application for drug quality assurance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbamazepineChromatography, Supercritical FluidReproducibility of ResultsChromatography, High Pressure LiquidDrug ContaminationAnticonvulsantsQuality ControlSoftware

Stichwörter der Autor:innen

ICH Q14SFCanalytical quality by designcarbamazepine

Substanzen

CarbamazepineAnticonvulsants

Autor:innen und Institutionen

  • Chromicent GmbH, Berlin Adlershof, Germany.
  • Freie Universität Berlin, Institute of Pharmacy, Berlin, Germany.

ORCID-Profile: Alexander H Schmidt, Maria Kristina Parr

Zitieren

APA

Schmidt, A. H., Stanic, M., & Parr, M. K. (2024). ICH Q14‐inspired novel approach to establish an SFC‐based purity method for carbamazepine. Drug Testing and Analysis. https://doi.org/10.1002/dta.3635

Vancouver

Schmidt AH, Stanic M, Parr MK. ICH Q14‐inspired novel approach to establish an SFC‐based purity method for carbamazepine. Drug Testing and Analysis. 2024. doi:10.1002/dta.3635

BibTeX
@article{Schmidt2024,
  author = {Schmidt, Alexander H and Stanic, Mijo and Parr, Maria Kristina},
  title = {ICH Q14‐inspired novel approach to establish an SFC‐based purity method for carbamazepine},
  journal = {Drug Testing and Analysis},
  year = {2024},
  doi = {10.1002/dta.3635}
}
Kostenlos starten →